Neuroprotective role of novel acid-sensing ion channel inhibitor in Multiple sclerosis (MS) disease (2020–2022)

Grant type:
Multiple Sclerosis Research Australia
Researchers:
Funded by:
Multiple Sclerosis Research Australia